Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

I've been adding shares as the share price has been dropping.

As I previously posted, all the options held by insiders are at an exercise price of eight cents or higher. Also any of the four products currently in the pipeline (many more than four with the various orphan indications for MANF) have the potential to be worth many times Amarantus' current market cap.

When thinking of selling a stock which I own at a higher price I ask myself if I didn't own the stock and had just heard about it would I be buying it here. If the answer is yes then I certainly wouldn't sell and in fact would be adding shares as I have been doing.

Amarantus is undervalued and is still unknown to the market at large.

I believe that by the end of the week we'll have a much better idea of Gerald's business plan for 2015.